Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
- 1.5k Downloads
Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence countries, India carries the highest burden of MDR-TB cases. We describe policy issues in India concerning MDR-TB diagnosis and management in a careful review of the literature including a systematic review of studies on the prevalence of MDR-TB. Of 995 articles published during 2001–2016 and retrieved from the PubMed, only 20 provided data on the population prevalence of MDR-TB. We further reviewed and describe diagnostic criteria and treatment algorithms in use and endorsed by the Revised National TB Control Program of India. We discuss problems encountered in treating MDR-TB patients with standardized regimens. Finally, we provide realistic suggestions for policymakers and program planners to improve the management and control of MDR-TB in India.
KeywordsMDR-TB policy India pathways to care primary acquired
Sachin Atre gratefully acknowledges funding support from US Department of State through the United States India Educational Foundation (USIEF) toward his one-year Fulbright-Nehru Postdoctoral fellowship at Harvard Medical School from September 2013. The authors thank Ms. Caroline McCallum for her editorial assistance.
Notes and References
- World Health Organization. (2015) Global Tuberculosis Control Report, (WHO/HTM/TB/2015.22) Geneva, Switzerland: World Health Organization.Google Scholar
- Yadav, A. et al (2012) Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh. Indian Journal of Chest Diseases and Allied Sciences 54(3): 161–163.Google Scholar
- Indian Council of Medical Research. (1959) Tuberculosis in India-A National Sample Survey: 1955–58 ICMR Special Report Series, New Delhi, No. 34.Google Scholar
- International Institute for Population Sciences (IIPS) and Macro International. (2007) National family health survey (NFHS-3), 2005–06, Vol I. Mumbai, India: IIPS; pp. 411-418, http://www.rchiips.org/NFHS/NFHS-3%20Data/VOL-1/India_volume_I_corrected_17oct08.pdf, accessed 14 November 2014.
- WHO Report. (2007) Global Tuberculosis Control. Surveillance, Planning and Financing. Geneva, Switzerland, World Health Organization WHO/HTM/TB/2007.376.Google Scholar
- World Health Organization. (2013) Global Tuberculosis Control Report. Geneva, Switzerland: World Health Organization.(WHO/HTM/TB/2013.13).Google Scholar
- Institute of Medicine (USA). (2012) Facing the reality of drug-resistant tuberculosis in India: Challenges and potential solutions: Summary of a joint workshop by the institute of medicine, the Indian national science academy, and the Indian council of medical research. Washington DC: National Academies Press, http://www.ncbi.nlm.nih.gov/books/NBK92617/pdf/TOC.pdf, accessed 14 November 2014.
- Bhat, J. et al (2015) Situation of drug resistant tuberculosis in Saharia tribe of central India. Indian Journal of Medical Research 141(5): 636–639.Google Scholar
- Myneedu, V. et al (2015) First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi. Journal of Epidemiology & Global Health 5: 365–373.Google Scholar
- Gupta, H., Kant, S., Jain, A., Natu, S.M. and Ahluwalia, S. (2013) Initial drug resistance pattern among pulmonary tuberculosis patients. Indian Journal of Tuberculosis 60(3): 154–161.Google Scholar
- Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian Journal of Medical Research 133(3): 312–315.Google Scholar
- Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian Journal of Medical Research 133(3): 308–311.Google Scholar
- Ramachandran, R. et al (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat. India International Journal of Tuberculosis and Lung Disease 13(9): 1154–1160.Google Scholar
- Joseph, B.V. et al (2009) Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India. International Journal of Tuberculosis and Lung Disease 13(4): 494–499.Google Scholar
- Jain, A., Mondal, R., Prasad, R., Singh, K. and Ahuja, R.C. (2008) Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian Journal of Medical Research 128(3): 300–306.Google Scholar
- Joseph, M.R., Shoby, C.T., Amma, G.R., Chauhan, L.S. and Paramasivan, C.N. (2007) Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. International Journal of Tuberculosis and Lung Disease 11(4): 443–449.Google Scholar
- Anuradha, B. et al (2006) Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001–2003. International Journal of Tuberculosis and Lung Disease 10(1): 58–62.Google Scholar
- Dhingra, V.K., Rajpal, S., Bhalla, P., Yadav, A., Jain, S.K. and Hanif, M. (2003) Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Journal of Communicable Diseases 35(2): 82–89.Google Scholar
- Negi, S.S., Gupta, S. and Lal, S. (2003) Drug resistance in tuberculosis in Delhi: A 2 year profile (2001–2002). Journal of Communicable Diseases 35(2): 74–81.Google Scholar
- Shah, A.R., Agarwal, S.K. and Shah, K.V. (2002) Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. International Journal of Tuberculosis and Lung Disease 6(12): 1098–1101.Google Scholar
- Paramasivan, C.N., Venkataraman, P., Chandrasekaran, V., Bhat, S. and Narayanan, P.R. (2002) Surveillance of drug resistance in tuberculosis in two districts of South India. International Journal of Tuberculosis and Lung Disease 6(6): 479–484.Google Scholar
- Although India has 29 States and 7 Union territories as of 2014. at the time of analysis data was only available for 28 States.Google Scholar
- Government of India Planning Commission data book. (2014) http://planningcommission.nic.in/data/datatable/0814/comp_databook.pdf, accessed 9 November 2014.
- Government of India – TB India. (2014) Revised National TB Control Program Annual Status Report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20INDIA%202014.pdf, accessed 15 April 2014.
- WHO/IUATLD. (2004) Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Geneva, Switzerland: World Health Organization. Report No.3.Google Scholar
- Billington, O.J., McHugh, T.D. and Gillespie, S.H. (1999) Physiological cost of rifampicin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 43(8): 1866–1869.Google Scholar
- Nardell, E. and Dharmadhikari, A. (2010) Turning off the spigot: Reducing drug-resistant tuberculosis transmission in resource-limited settings. International Journal of Tuberculosis and Lung Disease 14(10): 1233–1243.Google Scholar
- Waisbord, S. and Zimicki, S. http://www.popline.org/node/264997, accessed 9 November 2014.
- Weiss, M., Auer, C., Somma, D. and Abouihia, A (2006) Gender and tuberculosis: Cross-site analysis and implications of a multi-country study in Bangladesh, India, Malawi and Colombia. Special Programme for Research and Training in Tropical Diseases (UNICEF/UNDP/World Bank/WHO), TDR/SDR/SEB/RP/06.1. Geneva, Switzerland: WHO. Report Series No. 3, http://www.who.int/tdr/publications/documents/sebrep3.pdf, accessed 5 May 2014.
- Somma, D. et al (2008) Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia. International Journal of Tuberculosis and Lung Disease 12(7): 856–866.Google Scholar
- Jaggarajamma, K., Balambal, R. and Muniyandi, M. (2009) Perceptions of tuberculosis patients about private providers before and after implementation of Revised National Tuberculosis Control Program. Indian Journal of Tuberculosis 56(4): 185–190.Google Scholar
- Uplekar, M. et al (1998) Tuberculosis patients and practitioners in private clinics in India. International Journal of Tuberculosis and Lung Disease 2(4): 324–329.Google Scholar
- Pathania, V., Almeida, J. and Kochi, A. (1997) TB Patients and Private for Profit Health Care Providers in India. Geneva, Switzerland: World Health Organization, WHO/TB/97.223.1997.Google Scholar
- Srivastava, D.K. et al (2011) An assessment of knowledge and practices regarding tuberculosis in the Context of RNTCP among non-allopathic practitioners in Gwalior District. Online Journal of Health and Allied Sciences 10(2): 5.Google Scholar
- Datta, K., Bhatnagar, T. and Murhekar, M. (2010) Private practitioners’ knowledge, attitude and practices about tuberculosis, Hooghly district India. Indian Journal of Tuberculosis 57(4): 199–206.Google Scholar
- Uplekar, M., Juvekar, S. and Morankar, S. (1996) Tuberculosis patients and practitioners in private clinics, Bombay [Research Newsletter]. Foundation for Research in Community Health.Google Scholar
- Jagota, P. (1998) Case finding policy for national tuberculosis program. Indian Journal of Tuberculosis 45(1): 3–7.Google Scholar
- Central TB Division (CTD). (2012) Guidelines on programmatic management of drug resistant TB (PMDT) in India. Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi, http://tbcindia.gov.in/WriteReadData/l892s/8320929355Guidelines%20for%20PMDT%20in%20India%20-%20May%202012.pdf, accessed 21 February 2016.
- Government of India – TB India. (2015) Revised National TB Control Program Annual Status Report, New Delhi, http://tbcindia.gov.in/showfile.php?lid=3166, accessed 25 November 2015.
- Sachdeva, K. (2013) Management of tuberculosis: Indian Guidelines 2013, http://www.apiindia.org/medicine_update_2013/chap105.pdf, accessed 25 November 2015.
- Census of India (State Census). (2011) http://www.census2011.co.in/states.php, accessed on 25 November 2015.
- Global Alliance for TB drug development. (2007) Pathway to Patients: Charting the Dynamics of the Global TB Drug Market. New York: TB Alliance.Google Scholar
- Greaves, F., Ouyang, H., Pefole, M, MacCarthy, S. and Cash, R.A. (2007) Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India. International Journal of Tuberculosis and Lung Disease 11(1): 110–112.Google Scholar
- Pathania, V.S. (2001) Why the Indian TB control program must stop ignoring private practitioners. International Journal of Tuberculosis and Lung Disease 5(2): 201–203.Google Scholar
- Gupta, S., Gupta, S. and Behera, D. (2011) Reasons for interruption of anti-tubercular treatment as reported by patients with tuberculosis admitted in a tertiary care institute. Indian Journal of Tuberculosis 58(1): 11–17.Google Scholar
- Atre, S., D’Souza, D.T.B., Dholakia, Y.N. and Mistry, N.F. (2007) Observations on categorization of new TB cases: Implications for controlling drug resistance. International Journal of Tuberculosis and Lung Disease 11(10): 1152–1153.Google Scholar
- Otu, A., Umoh, V., Habib, A., Ameh, S., Lawson, L. and Ansa, V. (2013) Drug Resistance among Pulmonary Tuberculosis Patients in Calabar. Pulmonary Medicine doi: 10.1155/2013/235190.Google Scholar
- Park, S., Lee, W.C., Lee, D.H., Mitnick, C.D., Han, L. and Seung, K.J. (2004) Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease 8(3): 361–368.Google Scholar
- Government of India. TB India. (2013) Revised national TB control program annual status report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20India%202013.pdf, accessed 15 April 2014.
- World Bank. (2013) Public health expenditure data, http://data.worldbank.org/indicator/SH.XPD.PUBL.ZS, accessed 5 March 2014.
- Escombe, A.R. et al (2013) Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med 6(3): e1000043.Google Scholar